Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10871804rdf:typepubmed:Citationlld:pubmed
pubmed-article:10871804lifeskim:mentionsumls-concept:C0026769lld:lifeskim
pubmed-article:10871804lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:10871804lifeskim:mentionsumls-concept:C0029134lld:lifeskim
pubmed-article:10871804lifeskim:mentionsumls-concept:C1521970lld:lifeskim
pubmed-article:10871804pubmed:dateCreated2000-7-27lld:pubmed
pubmed-article:10871804pubmed:abstractTextThe frequency of multiple sclerosis (MS) with clinical onset before 16 years of age in different regions of Russia fluctuates from 2 to 10% of all MS patients. One of the most frequent signs of MS manifestation and/or exacerbation at this age is optic neuritis (ON). Forty-seven children with MS were observed in Moscow. Diagnosis of MS in every case was clinically definite and proved by serial MRI. Clinico-tomographic dissociation was noticed: numerous large lesions, typical for MS on T2 images were often seen in children with mild or moderate residual neurological symptoms. All patients had relapsing/remitting MS course, mean EDSS was 2.24+/-0.26. Thirty-eight children (80%) had ON at least once, ten (21.3%) - twice or more times. In several cases ON had subclinical course or might be missed and the damage of the optic nerve with partial atrophy was found only after complex ophthalmological investigation including visual evoked potentials. Thus, the clinical course of MS and ON have some peculiarities in children and may be genetically based. Analyses of allelic polymorphisms of HLA-DR and TNF loci on chromosome 6 was performed. Data from children with MS were compared with data from their parents, healthy controls and other MS patients from the same ethnic group. Children with MS had increased frequency of DR2(15) and TNF-a11, but not TNF-a9 as adult MS patients from the same ethnic group. The presence of TNF-a7, rare in adult patients, could be proposed as a marker of early MS onset.lld:pubmed
pubmed-article:10871804pubmed:languageenglld:pubmed
pubmed-article:10871804pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10871804pubmed:citationSubsetIMlld:pubmed
pubmed-article:10871804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10871804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10871804pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10871804pubmed:statusMEDLINElld:pubmed
pubmed-article:10871804pubmed:monthMaylld:pubmed
pubmed-article:10871804pubmed:issn1355-0284lld:pubmed
pubmed-article:10871804pubmed:authorpubmed-author:FavorovaO OOOlld:pubmed
pubmed-article:10871804pubmed:authorpubmed-author:GusevE IEIlld:pubmed
pubmed-article:10871804pubmed:authorpubmed-author:GusevaM RMRlld:pubmed
pubmed-article:10871804pubmed:authorpubmed-author:SudomoinaM...lld:pubmed
pubmed-article:10871804pubmed:authorpubmed-author:MaslovaO IOIlld:pubmed
pubmed-article:10871804pubmed:authorpubmed-author:BoikoA NANlld:pubmed
pubmed-article:10871804pubmed:authorpubmed-author:GusevaM EMElld:pubmed
pubmed-article:10871804pubmed:authorpubmed-author:BoikoS YSYlld:pubmed
pubmed-article:10871804pubmed:authorpubmed-author:BikovaO VOVlld:pubmed
pubmed-article:10871804pubmed:issnTypePrintlld:pubmed
pubmed-article:10871804pubmed:volume6 Suppl 2lld:pubmed
pubmed-article:10871804pubmed:ownerNLMlld:pubmed
pubmed-article:10871804pubmed:authorsCompleteYlld:pubmed
pubmed-article:10871804pubmed:paginationS152-5lld:pubmed
pubmed-article:10871804pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:10871804pubmed:meshHeadingpubmed-meshheading:10871804...lld:pubmed
pubmed-article:10871804pubmed:meshHeadingpubmed-meshheading:10871804...lld:pubmed
pubmed-article:10871804pubmed:meshHeadingpubmed-meshheading:10871804...lld:pubmed
pubmed-article:10871804pubmed:meshHeadingpubmed-meshheading:10871804...lld:pubmed
pubmed-article:10871804pubmed:meshHeadingpubmed-meshheading:10871804...lld:pubmed
pubmed-article:10871804pubmed:meshHeadingpubmed-meshheading:10871804...lld:pubmed
pubmed-article:10871804pubmed:meshHeadingpubmed-meshheading:10871804...lld:pubmed
pubmed-article:10871804pubmed:meshHeadingpubmed-meshheading:10871804...lld:pubmed
pubmed-article:10871804pubmed:meshHeadingpubmed-meshheading:10871804...lld:pubmed
pubmed-article:10871804pubmed:meshHeadingpubmed-meshheading:10871804...lld:pubmed
pubmed-article:10871804pubmed:meshHeadingpubmed-meshheading:10871804...lld:pubmed
pubmed-article:10871804pubmed:meshHeadingpubmed-meshheading:10871804...lld:pubmed
pubmed-article:10871804pubmed:meshHeadingpubmed-meshheading:10871804...lld:pubmed
pubmed-article:10871804pubmed:meshHeadingpubmed-meshheading:10871804...lld:pubmed
pubmed-article:10871804pubmed:meshHeadingpubmed-meshheading:10871804...lld:pubmed
pubmed-article:10871804pubmed:meshHeadingpubmed-meshheading:10871804...lld:pubmed
pubmed-article:10871804pubmed:meshHeadingpubmed-meshheading:10871804...lld:pubmed
pubmed-article:10871804pubmed:year2000lld:pubmed
pubmed-article:10871804pubmed:articleTitleClinico-immunogenetic characteristics of multiple sclerosis with optic neuritis in children.lld:pubmed
pubmed-article:10871804pubmed:affiliationDepartment of Neurology and Neurosurgery of the Russian State Medical University, Ostrovitianova 1, Moscow, Russia.lld:pubmed
pubmed-article:10871804pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10871804pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed